The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing. / read more /
FDA and CDC are investigating a multi-state Salmonella outbreak that appears to be caused by kratom, a plant used as an opioid substitute. / read more /
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale. / read more /
Researchers at the University of Illinois developed a method to transplant pancreatic islet cells from pigs more easily to treat type I diabetes. / read more /
The agency released draft guidance on the format for electronic submissions of NDA and BLA content regarding the planning of bioresearch monitoring inspections. / read more /
FDA approves Vertex’s cystic fibrosis drug, Symdeko (tezacaftor/ivacaftor and ivacaftor), which is made using a continuous manufacturing process. / read more /
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer’s and other neurodegenerative diseases. / read more /
The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden. / read more /
Early drug formulation and development
Catalent partners with innovators to accelerate programmes through the early phases of development, overcome a molecule's solubility and bioavailability challenges, and increase its likelihood of success in the clinic. / Read more/
SMA MicroParticle ICSTM
VAI is pleased to announce the addition of the SMA MicroParticle ICS line of non-viable particle counters that utilize the latest innovation in particle counting technology, to our contamination control portfolio. / Read more/
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.
